PT - JOURNAL ARTICLE AU - Seyed M. Karimi AU - Mahdi Majbouri AU - Kelsey White AU - Bert Little AU - W. Paul McKinney AU - Natalie DuPre TI - Spring Weather and COVID-19 Deaths in the U.S. AID - 10.1101/2020.06.20.20136259 DP - 2020 Jan 01 TA - medRxiv PG - 2020.06.20.20136259 4099 - http://medrxiv.org/content/early/2020/06/22/2020.06.20.20136259.short 4100 - http://medrxiv.org/content/early/2020/06/22/2020.06.20.20136259.full AB - This study used statistically robust regression models to control for a large set of confounders (including county-level time-invariant factors and time trends, regional-level daily variation, state-level social distancing measures, ultraviolet light, and levels of ozone and fine particulate matter, PM2.5) to estimate a reliable rather than simple regression for the impact of weather on the most accurately measured outcome of COVID-19, death. When the average minimum temperature within a five-day window increased by one degree Fahrenheit in spring 2020, daily death rates in northern U.S. counties increased by an estimated 5.1%. When ozone concentration over a five-day window rose by one part per billion, daily death rates in southern U.S. counties declined by approximately 2.0%. Maximum temperature, precipitation, PM2.5, and ultraviolet light did not significantly associate with COVID-19 mortality. The mechanism that may drive the observed association of minimum temperature on COVID-19 deaths in spring months may be increased mobility and contacts. The effect of ozone may be related to its disinfectant properties, but this requires further confirmation.Competing Interest StatementThe authors have declared no competing interest.Clinical TrialThis study is not a clinical trial.Funding StatementWe received no funding for this research.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:We did not need to apply for an IRB because all the data we used were publicly available with no personal identifiers. The unit of observation in this study is U.S. county. No patient record was used and no clinical trial was conducted.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll the data used in this study are publicly available. Data sources and the related links are provided in the text.